OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Newly Emerging Strategies in Antiviral Drug Discovery: Dedicated to Prof. Dr. Erik De Clercq on Occasion of His 80th Anniversary
Shujing Xu, Dang Ding, Xujie Zhang, et al.
Molecules (2022) Vol. 27, Iss. 3, pp. 850-850
Open Access | Times Cited: 25
Shujing Xu, Dang Ding, Xujie Zhang, et al.
Molecules (2022) Vol. 27, Iss. 3, pp. 850-850
Open Access | Times Cited: 25
Showing 25 citing articles:
Antiviral Protein–Protein Interaction Inhibitors
Violeta Marković, Anna Szczepańska, Łukasz Berlicki
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 5, pp. 3205-3231
Open Access | Times Cited: 10
Violeta Marković, Anna Szczepańska, Łukasz Berlicki
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 5, pp. 3205-3231
Open Access | Times Cited: 10
Recent advances of novel fourth generation EGFR inhibitors in overcoming C797S mutation of lung cancer therapy
Li Xu, Bing Xu, Jianshe Wang, et al.
European Journal of Medicinal Chemistry (2022) Vol. 245, pp. 114900-114900
Closed Access | Times Cited: 29
Li Xu, Bing Xu, Jianshe Wang, et al.
European Journal of Medicinal Chemistry (2022) Vol. 245, pp. 114900-114900
Closed Access | Times Cited: 29
Revolutionizing viral disease treatment: Phase separation and lysosome/exosome targeting as new areas and new paradigms for antiviral drug research
Shaoqing Du, Xueping Hu, Xinyong Liu, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 3, pp. 103888-103888
Closed Access | Times Cited: 5
Shaoqing Du, Xueping Hu, Xinyong Liu, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 3, pp. 103888-103888
Closed Access | Times Cited: 5
Overview of host-directed antiviral targets for future research and drug development
Xiaoxia Gu, Mengzhu Zheng, Ya Gao, et al.
Acta Pharmaceutica Sinica B (2025)
Open Access
Xiaoxia Gu, Mengzhu Zheng, Ya Gao, et al.
Acta Pharmaceutica Sinica B (2025)
Open Access
Antimicrobial peptides for novel antiviral strategies in the current post‐COVID‐19 pandemic
Maria Rosa Loffredo, Lucia Nencioni, Maria Luisa Mangoni, et al.
Journal of Peptide Science (2023) Vol. 30, Iss. 1
Open Access | Times Cited: 10
Maria Rosa Loffredo, Lucia Nencioni, Maria Luisa Mangoni, et al.
Journal of Peptide Science (2023) Vol. 30, Iss. 1
Open Access | Times Cited: 10
Discovery of new antiviral agents through artificial intelligence: In vitro and in vivo results
Roza Izmailyan, Mher Matevosyan, Hamlet Khachatryan, et al.
Antiviral Research (2024) Vol. 222, pp. 105818-105818
Closed Access | Times Cited: 2
Roza Izmailyan, Mher Matevosyan, Hamlet Khachatryan, et al.
Antiviral Research (2024) Vol. 222, pp. 105818-105818
Closed Access | Times Cited: 2
The discovery and design of novel HIV-1 capsid modulators and future perspectives
Dang Ding, Shujing Xu, Xujie Zhang, et al.
Expert Opinion on Drug Discovery (2022) Vol. 18, Iss. 1, pp. 5-12
Closed Access | Times Cited: 11
Dang Ding, Shujing Xu, Xujie Zhang, et al.
Expert Opinion on Drug Discovery (2022) Vol. 18, Iss. 1, pp. 5-12
Closed Access | Times Cited: 11
What Have We Learned by Resurrecting the 1918 Influenza Virus?
Brad Gilbertson, Kanta Subbarao
Annual Review of Virology (2023) Vol. 10, Iss. 1, pp. 25-47
Open Access | Times Cited: 6
Brad Gilbertson, Kanta Subbarao
Annual Review of Virology (2023) Vol. 10, Iss. 1, pp. 25-47
Open Access | Times Cited: 6
Antiviral Pathogenesis and Interventions: New Understandings and Developments
Abhinandan Patil, Neha Singh, Khushboo Bange
ACTA SCIENTIFIC MICROBIOLOGY (2023) Vol. 6, Iss. 8, pp. 02-14
Open Access | Times Cited: 4
Abhinandan Patil, Neha Singh, Khushboo Bange
ACTA SCIENTIFIC MICROBIOLOGY (2023) Vol. 6, Iss. 8, pp. 02-14
Open Access | Times Cited: 4
Solvation structure and dynamics of favipiravir in supercritical CO2. A molecular dynamics investigation
Ioannis Skarmoutsos, Jannis Samios
Journal of Molecular Liquids (2023) Vol. 392, pp. 123512-123512
Closed Access | Times Cited: 4
Ioannis Skarmoutsos, Jannis Samios
Journal of Molecular Liquids (2023) Vol. 392, pp. 123512-123512
Closed Access | Times Cited: 4
Nutritional and pharmacological potentials of the medicinal mushroom Ganoderma adspersum (Schulz.) Donk
Sana Hamrouni Zahmoul, Rim Ladhar Chaabouni, Ameny Srih, et al.
South African Journal of Botany (2024) Vol. 166, pp. 360-374
Open Access | Times Cited: 1
Sana Hamrouni Zahmoul, Rim Ladhar Chaabouni, Ameny Srih, et al.
South African Journal of Botany (2024) Vol. 166, pp. 360-374
Open Access | Times Cited: 1
Current and emerging pharmacotherapy for respiratory syncytial virus (RSV) infection in infants
Nicola Principi, Giovanni Autore, Serafina Perrone, et al.
Expert Opinion on Pharmacotherapy (2023) Vol. 24, Iss. 6, pp. 747-762
Closed Access | Times Cited: 3
Nicola Principi, Giovanni Autore, Serafina Perrone, et al.
Expert Opinion on Pharmacotherapy (2023) Vol. 24, Iss. 6, pp. 747-762
Closed Access | Times Cited: 3
Structural, Dynamical, and Entropic Differences between SARS-CoV and SARS-CoV-2 s2m Elements Using Molecular Dynamics Simulations
Adam H. Kensinger, Joseph A. Makowski, Kendy A. Pellegrene, et al.
ACS Physical Chemistry Au (2022) Vol. 3, Iss. 1, pp. 30-43
Open Access | Times Cited: 5
Adam H. Kensinger, Joseph A. Makowski, Kendy A. Pellegrene, et al.
ACS Physical Chemistry Au (2022) Vol. 3, Iss. 1, pp. 30-43
Open Access | Times Cited: 5
Multi‐Specific Binding Strategy
Yang Zhou, Shujing Xu, Dang Ding, et al.
(2024), pp. 141-163
Closed Access
Yang Zhou, Shujing Xu, Dang Ding, et al.
(2024), pp. 141-163
Closed Access
Targeting human inosine 5’ monophosphate dehydrogenase type 2 for anti-dengue lead identification – a computational approach
Lekshmi Radha Kesavan, Biju Charuvil Kamalan, Sreekumar Sivanandan
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-15
Closed Access
Lekshmi Radha Kesavan, Biju Charuvil Kamalan, Sreekumar Sivanandan
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-15
Closed Access
Design and synthesis of benzo[d]imidazo-6,7-dihydrobenzo[d] imidazo[2,1-b]thiazol-8(5H)-ones as potent anti-infective agents
Rakesh K. Bollikanda, Yana L. Esaulkova, Abburi Naga Pranathi, et al.
Medicinal Chemistry Research (2024) Vol. 33, Iss. 6, pp. 989-1002
Closed Access
Rakesh K. Bollikanda, Yana L. Esaulkova, Abburi Naga Pranathi, et al.
Medicinal Chemistry Research (2024) Vol. 33, Iss. 6, pp. 989-1002
Closed Access
Phytochemical-Based Potential Therapeutic Interventions in the Management of COVID-19
Tabassum Zafar, Ab Qayoom Naik, Bashirulla Shaik
(2024), pp. 105-125
Closed Access
Tabassum Zafar, Ab Qayoom Naik, Bashirulla Shaik
(2024), pp. 105-125
Closed Access
Involvement of E3 Ubiquitin Ligases in Viral Infections of the Human Host
Suchanda Verma, Anamika Ghatak
Viral Immunology (2024) Vol. 37, Iss. 9, pp. 419-431
Closed Access
Suchanda Verma, Anamika Ghatak
Viral Immunology (2024) Vol. 37, Iss. 9, pp. 419-431
Closed Access
Lenacapavir: a first-in-class HIV-1 capsid inhibitor for the treatment of multidrug-resistant HIV infections
Dang Ding, Dazhou Shi, Shujing Xu, et al.
Elsevier eBooks (2024), pp. 341-349
Closed Access
Dang Ding, Dazhou Shi, Shujing Xu, et al.
Elsevier eBooks (2024), pp. 341-349
Closed Access
Computational Modeling in the Development of Antiviral Agents
Priyank Purohit, Pobitra Borah, Sangeeta Hazarika, et al.
Challenges and advances in computational chemistry and physics (2023), pp. 109-136
Closed Access | Times Cited: 1
Priyank Purohit, Pobitra Borah, Sangeeta Hazarika, et al.
Challenges and advances in computational chemistry and physics (2023), pp. 109-136
Closed Access | Times Cited: 1
Amazonian medicinal plants efficiently inactivate Herpes and Chikungunya viruses
Catielen Paula Pavi, Isabella Dai Prá, Rafael Dorighello Cadamuro, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115476-115476
Open Access | Times Cited: 1
Catielen Paula Pavi, Isabella Dai Prá, Rafael Dorighello Cadamuro, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115476-115476
Open Access | Times Cited: 1
Structural, Dynamical, and Entropic Differences Between SARS-CoV and SARS-CoV-2 s2m Elements Using Molecular Dynamics Simulations
Adam H. Kensinger, Joseph A. Makowski, Kendy A. Pellegrene, et al.
(2022)
Open Access | Times Cited: 2
Adam H. Kensinger, Joseph A. Makowski, Kendy A. Pellegrene, et al.
(2022)
Open Access | Times Cited: 2
Antiviral Activity of Approved Anti-Inflammatory Drugs and Prospects for Drug Repurposing: A review
Ejlal A. A. ABDALLAH, Leena Abdulaziz, Esraa Elhadi, et al.
Journal of Advances in Medical and Pharmaceutical Sciences (2023) Vol. 25, Iss. 12, pp. 1-13
Open Access
Ejlal A. A. ABDALLAH, Leena Abdulaziz, Esraa Elhadi, et al.
Journal of Advances in Medical and Pharmaceutical Sciences (2023) Vol. 25, Iss. 12, pp. 1-13
Open Access
SARS-CoV-2: Novel Therapeutic Approaches for Diagnosis and Treatment
Robert B. Kargbo
ACS Medicinal Chemistry Letters (2022) Vol. 13, Iss. 7, pp. 999-1001
Open Access
Robert B. Kargbo
ACS Medicinal Chemistry Letters (2022) Vol. 13, Iss. 7, pp. 999-1001
Open Access
Structural, Dynamical, and Entropic Differences Between SARS-CoV and SARS-CoV-2 s2m Elements Using Molecular Dynamics Simulations
Adam H. Kensinger, Joseph A. Makowski, Kendy A. Pellegrene, et al.
(2022)
Open Access
Adam H. Kensinger, Joseph A. Makowski, Kendy A. Pellegrene, et al.
(2022)
Open Access
